Botanix Pharmaceuticals Limited (BXPHF PINK) stock market data APIs
$0.0933
0(0%)
as of September 17, 2025
Try our APIs with
free plan!
Botanix Pharmaceuticals Limited Financial Data Overview
Price chart is built with
Anychart
Botanix Pharmaceuticals Limited operates as a commercial dermatology company in Australia and the United States. The company's lead product is Sofdra (sofpironium) topical gel, a prescription anticholinergic medicine used on the skin to treat underarm sweating in adults and children 9 years of age and older. Its product pipeline includes BTX 1503, a transdermal gel formulation for the treatment of serious acne in adults and teenagers; BTX 1801 for treating staphylococcus aureus and methicillin resistant staphylococcus aureus; BTX 1702 for the treatment of papulopustular rosacea; and BTX 1204A for treating atopic dermatitis. The company was incorporated in 1984 and is based in West Perth, Australia.
Prev. Close
0.0933
Open
0.0933
High
0.0933
Low
0.0933
52 wk Range
0.0619-0.34
Market Cap
182 M
Shares Outstanding
1 961 M
Revenue
5 789 K
EPS
-0.0015
Beta
0.918
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Botanix Pharmaceuticals Limited data using free add-ons & libraries
Get Botanix Pharmaceuticals Limited Fundamental Data
Botanix Pharmaceuticals Limited Fundamental data includes:
- Net Revenue: 5 789 K
- EBITDA: -80 650 936
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2021-06-30
- EPS/Forecast: 0
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Botanix Pharmaceuticals Limited News
New
ASX Penny Stocks Spotlight: Botanix Pharmaceuticals And Two More
The Australian market is currently experiencing some nervousness, aligning with trends seen in other Asian markets as investors await the Federal Reserve's rate cut decision. Despite the cautious sent...
ASX Penny Stocks: Botanix Pharmaceuticals And 2 Other Promising Picks
Australian shares are showing resilience as they head into Week 31 with a slight uptick, buoyed by a significant trade deal between the U.S. and European Union that promises to bring stability to glob...
Discover 3 ASX Penny Stocks With Market Caps Over A$100M
Australian shares are set to close out the first half of the trading year on a positive note, buoyed by Wall Street's momentum towards all-time highs and a revitalized IPO market. Amid this optimism, ...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
